Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-024906
Filing Date
2024-10-08
Accepted
2024-10-08 19:09:53
Documents
2
Period of Report
2024-10-04

Document Format Files

Seq Description Document Type Size
1 form3-10082024_111049.html 3  
1 form3-10082024_111049.xml 3 1689
2 ex24-10082024_111051.htm EX-24 5225
  Complete submission text file 0001415889-24-024906.txt   8478
Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Issuer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ELEVATION ONCOLOGY, INC. 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106
Business Address
Jansen Valerie Malyvanh (Reporting) CIK: 0001889716 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40315 | Film No.: 241361226